Epivax Inc.
Providence, RI
- UEI
- NLAVQM513F18
- CAGE
- 473V2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Epivax Inc.
NLAVQM513F18
- Epivax Therapeutics Inc. YLPUE9JLKUR6
-
Epivax Inc.
NLAVQM513F18
- SAM.gov registration date
- Physical address
- 188 Valley St #424, Providence, RI 02909, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| PA21259, sbir, phase i, improving t cell responses in vaccines: prediction and validation using existing databases,… | Office of Financial Resources | $571,681 | |
| Validation and improvement of ispri-HCP: an innovative platform for immunogenicity risk assessment of process-related… | National Institute of Allergy and Infectious Diseases | $599,834 | |
| Ispri-HCP: CHO protein impurity immunogenicity risk prediction for improving biosimilar product development and… | FDA Office of Acquisition and Grant Services | $3,999,968 | |
| Bordetella pertussis immunogenicity prediction | CDC Pittsburgh | $200,692 | |
| GAA-item: personalizing the prediction of anti-therapeutic antibody response in pompe disease patients | National Center for Advancing Translational Sciences | $324,980 |
About Epivax Inc.
Epivax Inc. is a for-profit, woman-owned small business based in Rhode Island that specializes in immunoinformatics and computational biology. The company applies machine learning and predictive modeling approaches to evaluate and predict the immunogenicity of therapeutic proteins, biological impurities, and vaccine candidates.
Through prime federal contract awards, Epivax has conducted research and development related to predicting the immunogenicity of pathogens like Bordetella pertussis, with the goal of improving T cell responses in vaccines. The company has received purchase order and firm-fixed price contracts from agencies such as the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH) for these types of biomedical research projects. Epivax has not utilized any set-aside designations for its prime contract work.
Epivax has received prime federal grant funding from agencies like HHS, CDC, NIH, and the Food and Drug Administration (FDA) to support a range of immunoinformatics research efforts. Notable projects include improving T cell responses in vaccines through predictive modeling and validation, assessing the immunogenicity risk of process-related protein impurities in biological drugs, and developing a predictive model for host cell protein immunogenicity to facilitate biosimilar product development. Epivax has participated in programs like the NIH's Allergy and Infectious Diseases Research, CDC's Immunization Research, and FDA Research. Funding mechanisms utilized include formula grants, project grants, and cooperative agreements. Partners on these grants have included academic institutions like Saint Louis University.
Quick answers
What is Epivax Inc.'s UEI?
Epivax Inc.'s Unique Entity ID (UEI) in SAM.gov is NLAVQM513F18.
What is Epivax Inc.'s CAGE code?
Epivax Inc.'s CAGE code is 473V2.
What is Epivax Inc.'s primary NAICS code?
Epivax Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Epivax Inc. located?
Epivax Inc.'s physical address in SAM.gov is 188 Valley St #424, Providence, RI 02909, USA.
Is Epivax Inc. registered in SAM.gov?
Yes. Epivax Inc.'s SAM.gov registration is active through December 9, 2026.
What is Epivax Inc.'s most recent federal award?
Epivax Inc.'s most recent federal grant award is PA21259, sbir, phase i, improving t cell responses in vaccines: prediction and validation using existing databases,… (R43IP001225), from Office of Financial Resources, on September 30, 2023.
On GovTribe
See Epivax Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors